APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Felodipine Extended-Release Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Felodipine Extended-Release Tablets Market Outlook and Growth Opportunities 2026

Report ID 173991190427 December 2025194 pages

Choose your research edition.

Industry ResearchFelodipine Extended-Release Tablets Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Felodipine Extended-Release Tablets Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Felodipine Extended-Release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Felodipine Extended-Release Tablets Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Felodipine Extended-Release Tablets Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Felodipine Extended-Release Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Felodipine Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Felodipine Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Felodipine Extended-Release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Felodipine Extended-Release Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Felodipine Extended-Release Tablets market include By-Health, CSPC, Zhejiang Cheng Yi Pharmaceutical, Watsons, Schiff, Pfizer, Movefree, KAL and Doppelherz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Felodipine Extended-Release Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Felodipine Extended-Release Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Felodipine Extended-Release Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Felodipine Extended-Release Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Felodipine Extended-Release Tablets Segment by Company

By-Health

CSPC

Zhejiang Cheng Yi Pharmaceutical

Watsons

Schiff

Pfizer

Movefree

KAL

Doppelherz

Blackmores

AdvaCare

Felodipine Extended-Release Tablets Segment by Type

Tablets

Capsules

Felodipine Extended-Release Tablets Segment by Application

Hospital

Clinic

Pharmacy

Felodipine Extended-Release Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Felodipine Extended-Release Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Felodipine Extended-Release Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Felodipine Extended-Release Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Felodipine Extended-Release Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Felodipine Extended-Release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Felodipine Extended-Release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Felodipine Extended-Release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Felodipine Extended-Release Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Felodipine Extended-Release Tablets industry.

Chapter 3: Detailed analysis of Felodipine Extended-Release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Felodipine Extended-Release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Felodipine Extended-Release Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Felodipine Extended-Release Tablets Industry Trends Table 2. Felodipine Extended-Release Tablets Industry Drivers Table 3. Felodipine Extended-Release Tablets Industry Opportunities and Challenges Table 4. Felodipine Extended-Release Tablets Industry Restraints Table 5. Global Felodipine Extended-Release Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Felodipine Extended-Release Tablets Revenue Share by Company (2021-2026) Table 7. Global Felodipine Extended-Release Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Felodipine Extended-Release Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Felodipine Extended-Release Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Felodipine Extended-Release Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Felodipine Extended-Release Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Felodipine Extended-Release Tablets Company, Product Type & Application Table 13. Global Felodipine Extended-Release Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Felodipine Extended-Release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablets Table 18. Significant Companies of Capsules Table 19. Global Felodipine Extended-Release Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Felodipine Extended-Release Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Felodipine Extended-Release Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Felodipine Extended-Release Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Felodipine Extended-Release Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Felodipine Extended-Release Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Felodipine Extended-Release Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Felodipine Extended-Release Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Felodipine Extended-Release Tablets Sales Value Share by Type (2021-2026) Table 28. Global Felodipine Extended-Release Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Pharmacy Table 32. Global Felodipine Extended-Release Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Felodipine Extended-Release Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Felodipine Extended-Release Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Felodipine Extended-Release Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Felodipine Extended-Release Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Felodipine Extended-Release Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Felodipine Extended-Release Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Felodipine Extended-Release Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Felodipine Extended-Release Tablets Sales Value Share by Application (2021-2026) Table 41. Global Felodipine Extended-Release Tablets Sales Value Share by Application (2027-2032) Table 42. Global Felodipine Extended-Release Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Felodipine Extended-Release Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Felodipine Extended-Release Tablets Sales Market Share by Region (2021-2026) Table 45. Global Felodipine Extended-Release Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Felodipine Extended-Release Tablets Sales Market Share by Region (2027-2032) Table 47. Global Felodipine Extended-Release Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Felodipine Extended-Release Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Felodipine Extended-Release Tablets Sales Value Share by Region (2021-2026) Table 50. Global Felodipine Extended-Release Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Felodipine Extended-Release Tablets Sales Value Share by Region (2027-2032) Table 52. Global Felodipine Extended-Release Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Felodipine Extended-Release Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Felodipine Extended-Release Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Felodipine Extended-Release Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Felodipine Extended-Release Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Felodipine Extended-Release Tablets Sales Market Share by Country (2021-2026) Table 58. Global Felodipine Extended-Release Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Felodipine Extended-Release Tablets Sales Market Share by Country (2027-2032) Table 60. Global Felodipine Extended-Release Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Felodipine Extended-Release Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Felodipine Extended-Release Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Felodipine Extended-Release Tablets Sales Value Market Share by Country (2027-2032) Table 64. By-Health Company Information Table 65. By-Health Business Overview Table 66. By-Health Felodipine Extended-Release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. By-Health Felodipine Extended-Release Tablets Product Portfolio Table 68. By-Health Recent Development Table 69. CSPC Company Information Table 70. CSPC Business Overview Table 71. CSPC Felodipine Extended-Release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. CSPC Felodipine Extended-Release Tablets Product Portfolio Table 73. CSPC Recent Development Table 74. Zhejiang Cheng Yi Pharmaceutical Company Information Table 75. Zhejiang Cheng Yi Pharmaceutical Business Overview Table 76. Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Product Portfolio Table 78. Zhejiang Cheng Yi Pharmaceutical Recent Development Table 79. Watsons Company Information Table 80. Watsons Business Overview Table 81. Watsons Felodipine Extended-Release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Watsons Felodipine Extended-Release Tablets Product Portfolio Table 83. Watsons Recent Development Table 84. Schiff Company Information Table 85. Schiff Business Overview Table 86. Schiff Felodipine Extended-Release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Schiff Felodipine Extended-Release Tablets Product Portfolio Table 88. Schiff Recent Development Table 89. Pfizer Company Information Table 90. Pfizer Business Overview Table 91. Pfizer Felodipine Extended-Release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Pfizer Felodipine Extended-Release Tablets Product Portfolio Table 93. Pfizer Recent Development Table 94. Movefree Company Information Table 95. Movefree Business Overview Table 96. Movefree Felodipine Extended-Release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Movefree Felodipine Extended-Release Tablets Product Portfolio Table 98. Movefree Recent Development Table 99. KAL Company Information Table 100. KAL Business Overview Table 101. KAL Felodipine Extended-Release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. KAL Felodipine Extended-Release Tablets Product Portfolio Table 103. KAL Recent Development Table 104. Doppelherz Company Information Table 105. Doppelherz Business Overview Table 106. Doppelherz Felodipine Extended-Release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Doppelherz Felodipine Extended-Release Tablets Product Portfolio Table 108. Doppelherz Recent Development Table 109. Blackmores Company Information Table 110. Blackmores Business Overview Table 111. Blackmores Felodipine Extended-Release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Blackmores Felodipine Extended-Release Tablets Product Portfolio Table 113. Blackmores Recent Development Table 114. AdvaCare Company Information Table 115. AdvaCare Business Overview Table 116. AdvaCare Felodipine Extended-Release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. AdvaCare Felodipine Extended-Release Tablets Product Portfolio Table 118. AdvaCare Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Felodipine Extended-Release Tablets Distributors List Table 122. Felodipine Extended-Release Tablets Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Felodipine Extended-Release Tablets Product Image Figure 2. Global Felodipine Extended-Release Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Felodipine Extended-Release Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Felodipine Extended-Release Tablets Sales (2021-2032) & (K Units) Figure 5. Global Felodipine Extended-Release Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Felodipine Extended-Release Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablets Image Figure 10. Capsules Image Figure 11. Global Felodipine Extended-Release Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Felodipine Extended-Release Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Felodipine Extended-Release Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Felodipine Extended-Release Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Felodipine Extended-Release Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Felodipine Extended-Release Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Pharmacy Image Figure 20. Global Felodipine Extended-Release Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Felodipine Extended-Release Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Felodipine Extended-Release Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Felodipine Extended-Release Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Felodipine Extended-Release Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Felodipine Extended-Release Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Felodipine Extended-Release Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Felodipine Extended-Release Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Felodipine Extended-Release Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Felodipine Extended-Release Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Felodipine Extended-Release Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Felodipine Extended-Release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Felodipine Extended-Release Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Felodipine Extended-Release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Felodipine Extended-Release Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Felodipine Extended-Release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Felodipine Extended-Release Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Felodipine Extended-Release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Felodipine Extended-Release Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Felodipine Extended-Release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Felodipine Extended-Release Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Felodipine Extended-Release Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Capsules
Applications
  • Hospital
  • Clinic
  • Pharmacy
Companies covered
  • By-Health
  • CSPC
  • Zhejiang Cheng Yi Pharmaceutical
  • Watsons
  • Schiff
  • Pfizer
  • Movefree
  • KAL
  • Doppelherz
  • Blackmores
  • AdvaCare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Felodipine Extended-Release Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Felodipine Extended-Release Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Felodipine Extended-Release Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Felodipine Extended-Release Tablets Market Dynamics
  1. 2.1 Felodipine Extended-Release Tablets Industry Trends
  2. 2.2 Felodipine Extended-Release Tablets Industry Drivers
  3. 2.3 Felodipine Extended-Release Tablets Industry Opportunities and Challenges
  4. 2.4 Felodipine Extended-Release Tablets Industry Restraints
3 Felodipine Extended-Release Tablets Market by Company
  1. 3.1 Global Felodipine Extended-Release Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Felodipine Extended-Release Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Felodipine Extended-Release Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Felodipine Extended-Release Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Felodipine Extended-Release Tablets Company Ranking (2024-2026)
  6. 3.6 Global Felodipine Extended-Release Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Felodipine Extended-Release Tablets Company Product Type and Application
  8. 3.8 Global Felodipine Extended-Release Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Felodipine Extended-Release Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Felodipine Extended-Release Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Felodipine Extended-Release Tablets Market by Type
  1. 4.1 Felodipine Extended-Release Tablets Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Capsules
  4. 4.2 Global Felodipine Extended-Release Tablets Sales Volume by Type
  5. 4.2.1 Global Felodipine Extended-Release Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Felodipine Extended-Release Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Felodipine Extended-Release Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Felodipine Extended-Release Tablets Sales Value by Type
  9. 4.3.1 Global Felodipine Extended-Release Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Felodipine Extended-Release Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Felodipine Extended-Release Tablets Sales Value Share by Type (2021-2032)
5 Felodipine Extended-Release Tablets Market by Application
  1. 5.1 Felodipine Extended-Release Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Pharmacy
  5. 5.2 Global Felodipine Extended-Release Tablets Sales Volume by Application
  6. 5.2.1 Global Felodipine Extended-Release Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Felodipine Extended-Release Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Felodipine Extended-Release Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Felodipine Extended-Release Tablets Sales Value by Application
  10. 5.3.1 Global Felodipine Extended-Release Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Felodipine Extended-Release Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Felodipine Extended-Release Tablets Sales Value Share by Application (2021-2032)
6 Felodipine Extended-Release Tablets Regional Sales and Value Analysis
  1. 6.1 Global Felodipine Extended-Release Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Felodipine Extended-Release Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Felodipine Extended-Release Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Felodipine Extended-Release Tablets Sales by Region (2027-2032)
  5. 6.3 Global Felodipine Extended-Release Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Felodipine Extended-Release Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Felodipine Extended-Release Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Felodipine Extended-Release Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Felodipine Extended-Release Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Felodipine Extended-Release Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Felodipine Extended-Release Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Felodipine Extended-Release Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Felodipine Extended-Release Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Felodipine Extended-Release Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Felodipine Extended-Release Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Felodipine Extended-Release Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Felodipine Extended-Release Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Felodipine Extended-Release Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Felodipine Extended-Release Tablets Sales Value Share by Country, 2025 VS 2032
7 Felodipine Extended-Release Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Felodipine Extended-Release Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Felodipine Extended-Release Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Felodipine Extended-Release Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Felodipine Extended-Release Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Felodipine Extended-Release Tablets Sales by Country (2027-2032)
  6. 7.4 Global Felodipine Extended-Release Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Felodipine Extended-Release Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Felodipine Extended-Release Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Felodipine Extended-Release Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Felodipine Extended-Release Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Felodipine Extended-Release Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 By-Health
  2. 8.1.1 By-Health Company Information
  3. 8.1.2 By-Health Business Overview
  4. 8.1.3 By-Health Felodipine Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 By-Health Felodipine Extended-Release Tablets Product Portfolio
  6. 8.1.5 By-Health Recent Developments
  7. 8.2 CSPC
  8. 8.2.1 CSPC Company Information
  9. 8.2.2 CSPC Business Overview
  10. 8.2.3 CSPC Felodipine Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 CSPC Felodipine Extended-Release Tablets Product Portfolio
  12. 8.2.5 CSPC Recent Developments
  13. 8.3 Zhejiang Cheng Yi Pharmaceutical
  14. 8.3.1 Zhejiang Cheng Yi Pharmaceutical Company Information
  15. 8.3.2 Zhejiang Cheng Yi Pharmaceutical Business Overview
  16. 8.3.3 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Zhejiang Cheng Yi Pharmaceutical Felodipine Extended-Release Tablets Product Portfolio
  18. 8.3.5 Zhejiang Cheng Yi Pharmaceutical Recent Developments
  19. 8.4 Watsons
  20. 8.4.1 Watsons Company Information
  21. 8.4.2 Watsons Business Overview
  22. 8.4.3 Watsons Felodipine Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Watsons Felodipine Extended-Release Tablets Product Portfolio
  24. 8.4.5 Watsons Recent Developments
  25. 8.5 Schiff
  26. 8.5.1 Schiff Company Information
  27. 8.5.2 Schiff Business Overview
  28. 8.5.3 Schiff Felodipine Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Schiff Felodipine Extended-Release Tablets Product Portfolio
  30. 8.5.5 Schiff Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Felodipine Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Felodipine Extended-Release Tablets Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Movefree
  38. 8.7.1 Movefree Company Information
  39. 8.7.2 Movefree Business Overview
  40. 8.7.3 Movefree Felodipine Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Movefree Felodipine Extended-Release Tablets Product Portfolio
  42. 8.7.5 Movefree Recent Developments
  43. 8.8 KAL
  44. 8.8.1 KAL Company Information
  45. 8.8.2 KAL Business Overview
  46. 8.8.3 KAL Felodipine Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 KAL Felodipine Extended-Release Tablets Product Portfolio
  48. 8.8.5 KAL Recent Developments
  49. 8.9 Doppelherz
  50. 8.9.1 Doppelherz Company Information
  51. 8.9.2 Doppelherz Business Overview
  52. 8.9.3 Doppelherz Felodipine Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Doppelherz Felodipine Extended-Release Tablets Product Portfolio
  54. 8.9.5 Doppelherz Recent Developments
  55. 8.10 Blackmores
  56. 8.10.1 Blackmores Company Information
  57. 8.10.2 Blackmores Business Overview
  58. 8.10.3 Blackmores Felodipine Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Blackmores Felodipine Extended-Release Tablets Product Portfolio
  60. 8.10.5 Blackmores Recent Developments
  61. 8.11 AdvaCare
  62. 8.11.1 AdvaCare Company Information
  63. 8.11.2 AdvaCare Business Overview
  64. 8.11.3 AdvaCare Felodipine Extended-Release Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 AdvaCare Felodipine Extended-Release Tablets Product Portfolio
  66. 8.11.5 AdvaCare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Felodipine Extended-Release Tablets Value Chain Analysis
  2. 9.1.1 Felodipine Extended-Release Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Felodipine Extended-Release Tablets Sales Mode & Process
  6. 9.2 Felodipine Extended-Release Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Felodipine Extended-Release Tablets Distributors
  9. 9.2.3 Felodipine Extended-Release Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst